The Use of Hormonal Therapy: Peter Schnatz, Reading Health System

Video

As Peter Schnatz, DO, Reading Health System, completes his term as President of NAMS, he reflected on the initial goals he'd had before assuming his position. His primary initiative was to bring the best care they could to menopausal women. Schnatz said they'd been working really hard on reopening the conversation of the use and utilization of hormonal therapy.

As Peter Schnatz, DO, Reading Health System, completes his term as President of NAMS, he reflected on the initial goals he'd had before assuming his position. His primary initiative was to bring the best care they could to menopausal women. Schnatz said they'd been working really hard on reopening the conversation of the use and utilization of hormonal therapy. He believes the conversation should move to considering what's the appropriate dose of hormonal therapy via the appropriate route for the appropriate duration, and not think it should be "the lowest dose for the shortest duration".

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.